University of Southern California
USC Norris Comprehensive Cancer Center


Not logged in...


If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 9L-18-7


A Phase 1 Dose Escalation Trial of SKI-G-801 in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

Type: Treatment
Phase: Phase I
Status: Open to Accrual
Treatments:
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  George Yaghmour, M.D.
Other Trial Staff:  Simbiso Peresuh, Coordinator, Suraj Chandwani, D.M., Christine Duran, Coordinator, Donna Fernando, Coordinator, Hannah Trey, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.